CMA: pay-for-delay settlement “restrictive in its own right”
In its opening statement at the Competition Appeal Tribunal today, the UK competition authority said that pay-for-delay agreements between an antidepressant patent holder and generics manufacturers were “by nature antithetical to the competitive process”.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.